vs

Side-by-side financial comparison of PEDEVCO CORP (PED) and Septerna, Inc. (SEPN). Click either name above to swap in a different company.

Septerna, Inc. is the larger business by last-quarter revenue ($24.1M vs $23.1M, roughly 1.0× PEDEVCO CORP). PEDEVCO CORP runs the higher net margin — -36.8% vs -44.5%, a 7.7% gap on every dollar of revenue.

PEDEVCO Corp is an independent energy company specializing in the acquisition, exploration, development, and production of oil and natural gas assets. It primarily holds and operates onshore resource properties across continental US basins, serving domestic wholesale, utility, and industrial energy customer segments.

Septerna, Inc. is a clinical-stage biotechnology company focused on developing novel therapies targeting G protein-coupled receptors (GPCRs), a large family of cell surface proteins involved in many disease pathways. Its pipeline includes candidates for inflammatory, metabolic, and central nervous system disorders, addressing global unmet medical needs.

PED vs SEPN — Head-to-Head

Bigger by revenue
SEPN
SEPN
1.0× larger
SEPN
$24.1M
$23.1M
PED
Higher net margin
PED
PED
7.7% more per $
PED
-36.8%
-44.5%
SEPN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PED
PED
SEPN
SEPN
Revenue
$23.1M
$24.1M
Net Profit
$-8.5M
$-10.7M
Gross Margin
Operating Margin
-21.3%
-66.4%
Net Margin
-36.8%
-44.5%
Revenue YoY
118.2%
Net Profit YoY
-243.5%
EPS (diluted)
$-2.23
$-0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PED
PED
SEPN
SEPN
Q4 25
$23.1M
$24.1M
Q3 25
$7.0M
$21.5M
Q2 25
$7.0M
Q1 25
$8.7M
Q4 24
$10.6M
Q3 24
$9.1M
Q2 24
$11.8M
Q1 24
$8.1M
Net Profit
PED
PED
SEPN
SEPN
Q4 25
$-8.5M
$-10.7M
Q3 25
$-325.0K
$8.2M
Q2 25
$-1.7M
Q1 25
$140.0K
Q4 24
$5.9M
Q3 24
$2.9M
Q2 24
$2.7M
Q1 24
$773.0K
Operating Margin
PED
PED
SEPN
SEPN
Q4 25
-21.3%
-66.4%
Q3 25
-12.0%
12.2%
Q2 25
-32.2%
Q1 25
1.7%
Q4 24
-12.9%
Q3 24
31.3%
Q2 24
22.3%
Q1 24
7.6%
Net Margin
PED
PED
SEPN
SEPN
Q4 25
-36.8%
-44.5%
Q3 25
-4.7%
38.0%
Q2 25
-24.0%
Q1 25
1.6%
Q4 24
56.0%
Q3 24
32.2%
Q2 24
22.7%
Q1 24
9.5%
EPS (diluted)
PED
PED
SEPN
SEPN
Q4 25
$-2.23
$-0.23
Q3 25
$0.00
$0.18
Q2 25
$-0.02
Q1 25
$0.00
Q4 24
$2.69
Q3 24
$0.03
Q2 24
$0.03
Q1 24
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PED
PED
SEPN
SEPN
Cash + ST InvestmentsLiquidity on hand
$3.2M
$391.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$207.4M
$381.9M
Total Assets
$375.9M
$596.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PED
PED
SEPN
SEPN
Q4 25
$3.2M
$391.1M
Q3 25
$10.9M
$474.3M
Q2 25
$8.5M
Q1 25
$10.4M
Q4 24
$4.0M
Q3 24
$4.6M
Q2 24
$6.1M
Q1 24
$13.3M
Stockholders' Equity
PED
PED
SEPN
SEPN
Q4 25
$207.4M
$381.9M
Q3 25
$115.4M
$388.7M
Q2 25
$115.2M
Q1 25
$116.2M
Q4 24
$115.6M
Q3 24
$106.5M
Q2 24
$103.2M
Q1 24
$100.0M
Total Assets
PED
PED
SEPN
SEPN
Q4 25
$375.9M
$596.2M
Q3 25
$135.9M
$606.7M
Q2 25
$136.8M
Q1 25
$145.6M
Q4 24
$128.3M
Q3 24
$114.3M
Q2 24
$111.0M
Q1 24
$118.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PED
PED
SEPN
SEPN
Operating Cash FlowLast quarter
$-2.1M
$-15.0M
Free Cash FlowOCF − Capex
$-15.1M
FCF MarginFCF / Revenue
-62.4%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PED
PED
SEPN
SEPN
Q4 25
$-2.1M
$-15.0M
Q3 25
$7.4M
$168.8M
Q2 25
$-420.0K
Q1 25
$5.9M
Q4 24
$4.2M
Q3 24
$8.3M
Q2 24
$4.6M
Q1 24
$-4.3M
Free Cash Flow
PED
PED
SEPN
SEPN
Q4 25
$-15.1M
Q3 25
$168.8M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
PED
PED
SEPN
SEPN
Q4 25
-62.4%
Q3 25
785.3%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
PED
PED
SEPN
SEPN
Q4 25
0.3%
Q3 25
0.1%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Cash Conversion
PED
PED
SEPN
SEPN
Q4 25
Q3 25
20.65×
Q2 25
Q1 25
42.34×
Q4 24
0.71×
Q3 24
2.83×
Q2 24
1.71×
Q1 24
-5.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons